Page 99

Mayo 2016

641 artículos de revisión Ancho de distribución eritrocitaria y enfermedades cardiovasculares - H. Alcaíno et al ronary artery ectasia. Clin Appl Thromb Hemost 2012; 18 (2): 211-4. 23. Uysal OK, Duran M, Ozkan B, Sahin DY, Tekin K, Elbasan Z, et al. Red cell distribution width is associated with acute myocardial infarction in young patients. Cardiol J 2012; 19 (6): 597-602. 24. Sánchez-Chaparro MA, Calvo-Bonacho E, González Quintela A, Cabrera M, Sáinz JC, Fernández-Labandera C. Higher red blood cell distribution width is associated with the metabolic syndrome: results of the Ibermutuamur Cardiovascular RIsk assessment study. Diabetes Care 2010; 33 (3): e40. 25. Ertaş G, Aydin C, Sönmez O, Erdoğan E, Turfan M, Tasal A. Red cell distribution width predicts new-onset atrial fibrillation after coronary artery bypass grafting. Scand Cardiovasc J 2013; 47 (3): 132-5. 26. Nishizaki Y, Yamagami S, Suzuki H, Joki Y, Takahashi S, Sesoko M, et al. Red blood cell distribution width as an effective tool for detecting fatal heart failure in super-elderly patients. Intern Med 2012; 51 (17): 2271-6. 27. Huang  YL, Hu ZD, Liu SJ, Sun Y, Qin Q, Qin BD. Prognostic value of red blood cell distribution width for patients with heart failure: a systematic review and meta-analysis of cohort studies. PLoS One 2014; 9 (8): e104861 28. Su C, Liao LZ, Song Y, Xu ZW, Mei WY. The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: a systematic review and meta-analysis. J Thorac Dis 2014; 6 (10): 1429-40. 29. Zöller B, Melander O, Svensson P, Engström G. Red cell distribution width and risk for venous thromboembolism: a population-based cohort study. Thromb Res 2014; 133 (3): 334-9. 30. Abul Y, Ozsu S, Korkmaz A, Bulbul Y, Orem A, Ozlu T. Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism. Chron Respir Dis 2014; 11 (2): 73-81. 31. Karakilcik AZ, Halat R, Zerin M, Celik H, Nazligul Y. Effects of vitamin C and exercise on lipid profile, platelet anderythrocyte indices in young soccer players. J Sports Med Phys Fitness 2014; 54 (5): 665-71. 32. Semba RD, Patel KV, Ferrucci L, Sun K, Roy CN, Guralnik JM, et al. Serum antioxidants and inflammation predict red cell distribution width in older women: the Women’s Health and Aging Study I. Clin Nutr 2010; 29 (5): 600-4. 33. Inuzuka R, Abe J. Red blood cell distribution width as a link between ineffective erythropoiesis and chronic inflammation  in heart failure. Circ J 2015; 79 (5): 974-5. 34. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution  width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009; 133 (4): 628-32. 35. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width  in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 2009; 158 (4): 659-66. 36. Zalawadiya SK, Veeranna V, Panaich SS, Afonso L, Ghali JK. Gender and ethnic differences in red cell distribution widthand its association with mortality among low risk healthy United State adults. Am J Cardiol 2012; 109 (11): 1664-70. 37. Ujszaszi A, Molnar MZ, Czira ME, Novak M, Mucsi I. Renal function is independently associated with red cell distribution width in kidney transplant recipients: a potential new auxiliary parameter for the clinical evaluation of patients with chronic kidney disease. Br J Haematol 2013; 161 (5): 715-25. 38. van  Kimmenade  RR,  Mohammed AA,  Uthamalingam S,  van der Meer P,  Felker GM,  Januzzi JL Jr. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010; 12 (2): 129- 36. 39. Julich H, Willms A, Lukacs-Kornek V, Kornek M. Extracellular vesicle profiling and their use as potential disease specific biomarker. Front Immunol 2014; 5: 413. 40. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101 (3): 439-51. 41. Orozco AF, Lewis DE. Flow cytometric analysis of circulating  microparticles in plasma. Cytometry A 2010; 77 (6): 502-14. 42. Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014; 114 (2): 345-53. 43. Agouni A, Andriantsitohaina R, Martínez MC. Microparticles  as biomarkers of vascular dysfunction in metabolic syndrome and its individual components. Curr Vasc Pharmacol 2014; 12 (3): 483-92. 44. Schindler SM, Little JP, Klegeris A. Microparticles: a new perspective in central nervous system disorders. Biomed Res Int 2014: 756327.  45. Antonyak MA, Cerione RA. Microvesicles as mediators of intercellular communication in cancer. Methods Mol Biol 2014; 1165: 147-73. 46. Andriantsitohaina R, Gaceb A, Vergori L, Martínez MC. Microparticles  as regulators of  cardiovascular  inflammation. Trends Cardiovasc Med 2012; 22 (4): 88-92. Rev Med Chile 2016; 144: 634-642


Mayo 2016
To see the actual publication please follow the link above